SE0200943D0 - Mutant protein - Google Patents

Mutant protein

Info

Publication number
SE0200943D0
SE0200943D0 SE0200943A SE0200943A SE0200943D0 SE 0200943 D0 SE0200943 D0 SE 0200943D0 SE 0200943 A SE0200943 A SE 0200943A SE 0200943 A SE0200943 A SE 0200943A SE 0200943 D0 SE0200943 D0 SE 0200943D0
Authority
SE
Sweden
Prior art keywords
protein
immunoglobulin
binding
mutated
glutamine
Prior art date
Application number
SE0200943A
Other languages
English (en)
Swedish (sv)
Inventor
Sophia Hober
Original Assignee
Amersham Biosciences Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20287415&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0200943(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amersham Biosciences Ab filed Critical Amersham Biosciences Ab
Priority to SE0200943A priority Critical patent/SE0200943D0/xx
Publication of SE0200943D0 publication Critical patent/SE0200943D0/xx
Priority to CN201110407855.2A priority patent/CN102532284B/zh
Priority to CN2011104134586A priority patent/CN102558318A/zh
Priority to ES17166519T priority patent/ES2783876T3/es
Priority to EP08004374.8A priority patent/EP1972689B1/en
Priority to CN038067935A priority patent/CN1642976B/zh
Priority to EP17166519.3A priority patent/EP3249047B1/en
Priority to ES08004374.8T priority patent/ES2634145T3/es
Priority to CA2479896A priority patent/CA2479896C/en
Priority to AT03713152T priority patent/ATE431360T1/de
Priority to CN2011104078321A priority patent/CN102516371A/zh
Priority to DK17166519.3T priority patent/DK3249047T3/da
Priority to DE60327606T priority patent/DE60327606D1/de
Priority to AU2003217119A priority patent/AU2003217119B2/en
Priority to KR1020127028734A priority patent/KR101307651B1/ko
Priority to US10/508,625 priority patent/US7834158B2/en
Priority to PCT/SE2003/000475 priority patent/WO2003080655A1/en
Priority to KR1020127028735A priority patent/KR101307714B1/ko
Priority to KR1020047015303A priority patent/KR101067181B1/ko
Priority to CN2011104078514A priority patent/CN102516372A/zh
Priority to CN2011104134571A priority patent/CN102558317A/zh
Priority to KR1020107026798A priority patent/KR101307700B1/ko
Priority to EP03713152A priority patent/EP1485407B2/en
Priority to JP2003578408A priority patent/JP4391830B2/ja
Priority to ES03713152T priority patent/ES2325362T5/es
Priority to DK08004374.8T priority patent/DK1972689T3/da
Priority to US11/363,078 priority patent/US7709209B2/en
Priority to US11/374,532 priority patent/US20060194950A1/en
Priority to US12/568,854 priority patent/US8354510B2/en
Priority to US12/900,958 priority patent/US8198404B2/en
Priority to US13/488,662 priority patent/US9156892B2/en
Priority to US13/740,793 priority patent/US9296791B2/en
Priority to US14/845,817 priority patent/US9534023B2/en
Priority to US15/367,640 priority patent/US10918971B2/en
Priority to US17/153,015 priority patent/US20210162319A1/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/24—Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • B01J20/289—Phases chemically bonded to a substrate, e.g. to silica or to polymers bonded via a spacer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244—Non-macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00—Aspects relating to sorbent materials
    • B01J2220/40—Aspects relating to the composition of sorbent or filter aid materials
    • B01J2220/44—Materials comprising a mixture of organic materials
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00—Aspects relating to sorbent materials
    • B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
    • B01J2220/52—Sorbents specially adapted for preparative chromatography
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
SE0200943A 2002-03-25 2002-03-25 Mutant protein SE0200943D0 (sv)

Priority Applications (35)

Application Number Priority Date Filing Date Title
SE0200943A SE0200943D0 (sv) 2002-03-25 2002-03-25 Mutant protein
ES03713152T ES2325362T5 (es) 2002-03-25 2003-03-20 Una proteína de unión a inmunoglobulina mutada
DK08004374.8T DK1972689T3 (da) 2002-03-25 2003-03-20 Et muteret immunoglobulin-bindende protein
US10/508,625 US7834158B2 (en) 2002-03-25 2003-03-20 Mutated immunoglobulin-binding protein
KR1020047015303A KR101067181B1 (ko) 2002-03-25 2003-03-20 돌연변이된 면역글로불린-결합 단백질
ES17166519T ES2783876T3 (es) 2002-03-25 2003-03-20 Proteína mutante
EP08004374.8A EP1972689B1 (en) 2002-03-25 2003-03-20 A mutated immunoglobulin-binding protein
CN038067935A CN1642976B (zh) 2002-03-25 2003-03-20 一种突变的免疫球蛋白-结合蛋白
EP17166519.3A EP3249047B1 (en) 2002-03-25 2003-03-20 Mutant protein
ES08004374.8T ES2634145T3 (es) 2002-03-25 2003-03-20 Proteína de unión a inmunoglobulinas mutada
CA2479896A CA2479896C (en) 2002-03-25 2003-03-20 A mutated immunoglobulin-binding protein
AT03713152T ATE431360T1 (de) 2002-03-25 2003-03-20 Mutiertes immunoglobulinbindendes protein
CN2011104078321A CN102516371A (zh) 2002-03-25 2003-03-20 一种突变的免疫球蛋白-结合蛋白
DK17166519.3T DK3249047T3 (en) 2002-03-25 2003-03-20 Mutantprotein
DE60327606T DE60327606D1 (de) 2002-03-25 2003-03-20 Mutiertes immunoglobulinbindendes protein
AU2003217119A AU2003217119B2 (en) 2002-03-25 2003-03-20 A mutated immunoglobulin-binding protein
KR1020127028734A KR101307651B1 (ko) 2002-03-25 2003-03-20 돌연변이된 면역글로불린-결합 단백질
CN201110407855.2A CN102532284B (zh) 2002-03-25 2003-03-20 一种突变的免疫球蛋白-结合蛋白
PCT/SE2003/000475 WO2003080655A1 (en) 2002-03-25 2003-03-20 A mutated immunoglobulin-binding protein
KR1020127028735A KR101307714B1 (ko) 2002-03-25 2003-03-20 돌연변이된 면역글로불린-결합 단백질
CN2011104134586A CN102558318A (zh) 2002-03-25 2003-03-20 一种突变的免疫球蛋白-结合蛋白
CN2011104078514A CN102516372A (zh) 2002-03-25 2003-03-20 一种突变的免疫球蛋白-结合蛋白
CN2011104134571A CN102558317A (zh) 2002-03-25 2003-03-20 一种突变的免疫球蛋白-结合蛋白
KR1020107026798A KR101307700B1 (ko) 2002-03-25 2003-03-20 돌연변이된 면역글로불린-결합 단백질
EP03713152A EP1485407B2 (en) 2002-03-25 2003-03-20 A mutated immunoglobulin-binding protein
JP2003578408A JP4391830B2 (ja) 2002-03-25 2003-03-20 変異免疫グロブリン結合タンパク質
US11/363,078 US7709209B2 (en) 2002-03-25 2006-02-27 Protein ligands
US11/374,532 US20060194950A1 (en) 2002-03-25 2006-03-13 Mutant protein
US12/568,854 US8354510B2 (en) 2002-03-25 2009-09-29 Mutant protein
US12/900,958 US8198404B2 (en) 2002-03-25 2010-10-08 Mutated immunoglobulin-binding protein
US13/488,662 US9156892B2 (en) 2002-03-25 2012-06-05 Mutated immunoglobulin-binding protein
US13/740,793 US9296791B2 (en) 2002-03-25 2013-01-14 Mutant protein
US14/845,817 US9534023B2 (en) 2002-03-25 2015-09-04 Mutated immunoglobulin-binding protein
US15/367,640 US10918971B2 (en) 2002-03-25 2016-12-02 Mutated immunoglobulin-binding protein
US17/153,015 US20210162319A1 (en) 2002-03-25 2021-01-20 Mutated Immunoglobulin-Binding Polypeptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0200943A SE0200943D0 (sv) 2002-03-25 2002-03-25 Mutant protein

Publications (1)

Publication Number Publication Date
SE0200943D0 true SE0200943D0 (sv) 2002-03-25

Family

ID=20287415

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0200943A SE0200943D0 (sv) 2002-03-25 2002-03-25 Mutant protein

Country Status (13)

Country Link
US (9) US7834158B2 (da)
EP (3) EP1972689B1 (da)
JP (1) JP4391830B2 (da)
KR (4) KR101307714B1 (da)
CN (6) CN102516372A (da)
AT (1) ATE431360T1 (da)
AU (1) AU2003217119B2 (da)
CA (1) CA2479896C (da)
DE (1) DE60327606D1 (da)
DK (2) DK1972689T3 (da)
ES (3) ES2634145T3 (da)
SE (1) SE0200943D0 (da)
WO (1) WO2003080655A1 (da)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0200943D0 (sv) 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
SE0301936D0 (sv) * 2003-06-30 2003-06-30 Affibody Ab New polypeptide
SE0400274D0 (sv) * 2004-02-09 2004-02-09 Affibody Ab New polypeptide
EP2251425B1 (en) * 2004-07-06 2016-04-20 Kaneka Corporation Process for producing protein A-like protein with use of Brevibacillus genus bacterium
EP1830947A4 (en) * 2004-12-14 2012-04-18 Ge Healthcare Bio Sciences Ab CLEANING OF IMMUNOGLOBULINS
US8728828B2 (en) 2004-12-22 2014-05-20 Ge Healthcare Bio-Sciences Ab Purification of immunoglobulins
ATE490268T1 (de) * 2005-03-01 2010-12-15 Affibody Ab Tnf-alhpa-bindendes polypeptid, anwendungen davon und verfahren, bei denen dieses verwendet wird
EP1992692B1 (en) * 2006-02-21 2013-01-09 Protenova Co., Ltd. Immunoglobulin affinity ligand
CA2664530C (en) 2006-09-29 2015-11-17 Ge Healthcare Bio-Sciences Ab Chromatography ligand comprising domain c from staphyloccocus aureus protein a for antibody isolation
WO2008127457A2 (en) 2006-12-06 2008-10-23 Repligen Corporation Nucleic acids encoding recombinant protein a
JP5522723B2 (ja) * 2007-05-21 2014-06-18 ノマディックバイオサイエンス株式会社 新規ポリペプチド，アフィニティークロマトグラフィー用材，及びイムノグロブリンの分離及び／又は精製方法
SG149759A1 (en) 2007-07-10 2009-02-27 Millipore Corp Media for affinity chromatography
GB2452301A (en) 2007-08-30 2009-03-04 Ge Healthcare Bio Sciences Ab Sterilization Method
KR101104417B1 (ko) * 2008-05-09 2012-01-16 한국생명공학연구원 단백질 ｇ 변형체를 이용한 항체의 특이적 공유결합 커플링방법
WO2009138484A2 (en) * 2008-05-15 2009-11-19 Novo Nordisk A/S Antibody purification process
US9238810B2 (en) 2008-06-05 2016-01-19 Affibody Ab Polypeptide
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
EP2339339A4 (en) * 2008-09-25 2016-10-12 Jsr Corp CHARGE FOR AFFINITY CHROMATOGRAPHY
JP5229888B2 (ja) * 2008-09-30 2013-07-03 独立行政法人産業技術総合研究所 弱酸性域での易解離性を向上したプロテインａ変異型タンパク質及び抗体捕捉剤
JP6113404B2 (ja) * 2008-10-29 2017-04-12 アブリンクス エン．ヴェー． 単一ドメイン抗原結合分子の精製方法
SG162687A1 (en) * 2008-12-24 2010-07-29 Millipore Corp Caustic stable chromatography ligands
CN102272145B (zh) * 2009-01-12 2014-07-30 通用电气健康护理生物科学股份公司 亲和色谱基质
US9403883B2 (en) 2009-03-24 2016-08-02 Kaneka Corporation Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand
WO2011118699A1 (ja) 2010-03-24 2011-09-29 株式会社カネカ 免疫グロブリンに特異的に結合するタンパク質および免疫グロブリン結合性アフィニティーリガンド
WO2011125673A1 (ja) 2010-03-31 2011-10-13 Jsr株式会社 アフィニティークロマトグラフィー用充填剤
US20130052209A1 (en) 2010-04-23 2013-02-28 Purdue Research Foundation Protein drug formulations and packages
WO2012001142A1 (en) 2010-07-02 2012-01-05 Novo Nordisk A/S Improved antibody binding affinity ligands
CA2815267C (en) * 2010-10-27 2019-06-25 Spiber Technologies Ab Spider silk fusion protein structures for binding to an organic target
CN103228328A (zh) * 2010-11-29 2013-07-31 通用电气健康护理生物科学股份公司 亲和色谱基质
JP5974343B2 (ja) * 2010-12-20 2016-08-23 ジーイー・ヘルスケア・バイオプロセス・アールアンドディ・アクチボラグ アフィニティークロマトグラフィーマトリックス
CN103269761B (zh) 2010-12-20 2016-05-18 通用电气健康护理生物科学股份公司 亲和色谱基质
US9051375B2 (en) 2010-12-21 2015-06-09 The University Of Western Ontario Alkali-resistant variants of protein A and their use in affinity chromatography
US9040661B2 (en) 2010-12-21 2015-05-26 Jsr Corporation Support for affinity chromatography and method for isolating immunoglobulin
EP2657254A4 (en) * 2010-12-24 2014-01-08 Asahi Kasei Medical Co Ltd PROCESS FOR IMMOBILIZING THE TEMPERATURE-REACTIVE PROTEIN A
CN103299231B (zh) 2011-01-20 2017-07-21 通用电气医疗集团生物科学公司 光扫描***
WO2012124145A1 (ja) 2011-03-15 2012-09-20 オムロン株式会社 演算ユニット、支援装置、支援プログラム、支援プログラムを格納した記憶媒体、および、支援装置における動作方法
JP6038774B2 (ja) 2011-03-24 2016-12-07 株式会社カネカ タンパク性物質結合性低分子化合物
WO2012133342A1 (ja) 2011-03-25 2012-10-04 株式会社カネカ 免疫グロブリン結合性新規ポリペプチド
JP5802830B2 (ja) * 2011-06-05 2015-11-04 アップル インコーポレイテッド 複数のアプリケーションから受信した通知を表示するためのシステムおよび方法
SG10201604559TA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
US9657055B2 (en) 2011-11-30 2017-05-23 Ge Healthcare Bioprocess R&D Ab Affinity chromatography matrix
WO2013147691A1 (en) 2012-03-28 2013-10-03 Ge Healthcare Bio-Sciences Ab Affinity chromatography matrix
US9856308B2 (en) * 2012-05-02 2018-01-02 Spiber Technologies Ab Spider silk fusion protein structures incorporating immunoglobulin fragments as affinity ligands
JP6335785B2 (ja) 2012-09-03 2018-05-30 株式会社カネカ ミックスモード抗体アフィニティー分離マトリックスとそれを用いた精製方法および標的分子
CN104718453B (zh) 2012-10-03 2017-03-08 Gyros专利公司 酸性条件下分析物测定用方法和试剂盒
US20150328563A1 (en) 2012-12-14 2015-11-19 Ge Healthcare Bio-Sciences Ab Method for Cleaning of Packed Bed Chromatography Columns
CN104059133B (zh) * 2013-03-18 2019-03-15 南京金斯瑞生物科技有限公司 一类突变的具有高耐碱特性的蛋白a及其应用
CN103214563B (zh) * 2013-03-26 2015-09-30 江南大学 一种性能改进的重组金黄色葡萄球菌蛋白a亲和配基及其构建方法
US9896486B2 (en) 2013-07-10 2018-02-20 Ge Healthcare Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10208094B2 (en) 2013-09-04 2019-02-19 Protenova Co., Ltd. Multimeric immunoglobulin-binding domain
EP3042954A4 (en) * 2013-09-06 2017-03-22 Kaneka Corporation Dissociation capacity-boosted ligand for affinity dissociation matrix
CN105555795A (zh) 2013-09-17 2016-05-04 株式会社钟化 新抗体纯化方法和由该方法得到的抗体、以及使用了阳离子交换基团的新抗体纯化法和由该方法得到的抗体
CN103540588B (zh) * 2013-10-08 2016-06-08 杨波 一种基因工程改造的免疫球蛋白-亲和蛋白
WO2015056680A1 (ja) 2013-10-15 2015-04-23 株式会社カネカ 多孔質セルロースビーズの製造方法
EP3059320A4 (en) 2013-10-15 2017-06-21 Kaneka Corporation Production method for porous cellulose beads, and absorbent employing same
WO2015056681A1 (ja) 2013-10-15 2015-04-23 株式会社カネカ 多孔質セルロースビーズの製造方法およびそれを用いた吸着体
CN104945488B (zh) * 2014-03-27 2020-02-18 迈格生物医药（上海）有限公司 一种具有免疫球蛋白结合能力的多肽
CN105481954B (zh) * 2014-09-16 2021-03-26 亿一生物制药(北京)有限公司 一种重组蛋白a及其应用
JP6369807B2 (ja) * 2014-10-21 2018-08-08 株式会社プロテイン・エクスプレス プロテインｌ変異体
US11566082B2 (en) * 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
CN116731129A (zh) 2014-12-17 2023-09-12 思拓凡生物工艺研发有限公司 修饰的κ轻链-结合多肽
WO2016121703A1 (ja) 2015-01-26 2016-08-04 株式会社カネカ 変異型免疫グロブリンκ鎖可変領域結合性ペプチド
WO2016121701A1 (ja) 2015-01-26 2016-08-04 株式会社カネカ 免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス
EP3255058B1 (en) 2015-02-05 2021-03-24 Mitsubishi Chemical Corporation Protein having affinity to immunoglobulin, and affinity separation medium and column for liquid chromatography using same
US10723769B2 (en) * 2015-03-26 2020-07-28 Jsr Corporation Immunoglobulin-binding protein and affinity carrier using same
CN106188251B (zh) * 2015-05-06 2020-07-31 上海迈泰君奥生物技术有限公司 一种免疫球蛋白结合蛋白突变体及其用途
JPWO2017014261A1 (ja) * 2015-07-22 2018-04-26 株式会社カネカ 抗体様タンパク質の精製方法
CN107849095A (zh) * 2015-07-22 2018-03-27 株式会社钟化 酸性pH范围内的抗体结合能力降低的抗体结合性蛋白质
GB201515339D0 (en) 2015-08-28 2015-10-14 Ge Healthcare Bio Sciences Ab A seperation matrix and a method of seperating antibodies
KR101993845B1 (ko) * 2016-02-18 2019-06-28 (주)에이피테크놀로지 알칼리 저항성이 증대된 항체 친화성 리간드
WO2017191748A1 (ja) * 2016-05-02 2017-11-09 株式会社カネカ 改変型免疫グロブリンκ鎖可変領域結合性ペプチド
WO2017195638A1 (ja) 2016-05-09 2017-11-16 株式会社カネカ 抗体またはκ鎖可変領域含有抗体断片の精製方法
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
CN109311949B (zh) * 2016-05-11 2022-09-16 思拓凡生物工艺研发有限公司 储存分离基质的方法
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
ES2909833T3 (es) 2016-05-11 2022-05-10 Cytiva Bioprocess R & D Ab Método de limpieza y/o desinfección de una matriz de separación
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
ES2874974T3 (es) 2016-05-11 2021-11-05 Cytiva Bioprocess R & D Ab Matriz de separación
KR101857953B1 (ko) 2016-07-06 2018-05-16 아미코젠주식회사 알칼리 내성이 증가된 변이 면역글로불린 결합 단백질
CN106117324A (zh) * 2016-07-29 2016-11-16 湖北爱晟生物科技有限公司 重组蛋白a及其编码基因和应用
KR102578256B1 (ko) * 2016-08-11 2023-09-15 리플리겐 코포레이션 친화성 크로마토그래피를 위한 알칼리 안정 fc-결합 단백질
WO2018048941A2 (en) * 2016-09-08 2018-03-15 The Board Of Trustees Of The Leland Stanford Junior University Use of high affinity monoclonal antibody product binders to increase the duration of action of therapeutic monoclonal antibody products in a biologic tissue
CN106543274B (zh) * 2016-10-18 2020-10-27 天津大学 一种对抗体具有特异性结合作用的a蛋白结构域z的衍生物及其应用
JP2020504172A (ja) 2016-12-12 2020-02-06 フラー エス．アー．エール．エル． 免疫グロブリン結合ポリペプチドおよびオリゴペプチドの免疫グロブリン結合容量を増加するための組成物および方法
GB201703116D0 (en) 2017-02-27 2017-04-12 Ge Healthcare Bioprocess R&D Ab A seperation matrix and a method of seperating antibodies
WO2019030156A1 (en) 2017-08-07 2019-02-14 Repligen Corporation FC BINDING PROTEINS WITH CYSTEINE IN THE C-TERMINAL HELICAL REGION
CN109721645A (zh) * 2017-12-29 2019-05-07 兆生生物科技南京有限公司 一种基因突变的蛋白a及其应用
US11155575B2 (en) 2018-03-21 2021-10-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbent, devices and methods
JP7335881B2 (ja) * 2018-08-24 2023-08-30 Jsr株式会社 イムノグロブリン結合タンパク質、及びそれを用いたアフィニティー担体
WO2020075670A1 (ja) * 2018-10-10 2020-04-16 国立大学法人鹿児島大学 ＩｇＧ結合性ペプチドを含む固相担体及びＩｇＧの分離方法
EP3917942A1 (en) * 2019-02-01 2021-12-08 Navigo Proteins Gmbh Immunoglobulin binding proteins for affinity purification
WO2020196938A1 (ko) * 2019-03-25 2020-10-01 아미코젠주식회사 불순물 제거능이 우수한 항체 정제용 레진
GB201904125D0 (en) 2019-03-26 2019-05-08 Ge Healthcare Bio Sciences Ab Method for sanitization of a chromatography column
JP2022530852A (ja) * 2019-04-17 2022-07-04 ブリストル－マイヤーズ スクイブ カンパニー クロマトグラフィー樹脂の再生方法
WO2020221781A1 (en) 2019-04-29 2020-11-05 Cytiva Bioprocess R&D Ab Method for separation of antibodies or antibody fragments being devoid of an fc region capable of binding to protein a
CN112210013A (zh) 2019-07-03 2021-01-12 拜奥普罗塞亚科技有限责任公司 碱耐受性亲和色谱配体
EP4049684A4 (en) 2019-10-18 2023-10-25 Nihon Medi-Physics Co., Ltd RI MARKED HUMANIZED ANTIBODIES
CN111057153B (zh) * 2019-12-06 2021-09-07 广州康盛生物科技股份有限公司 一种免疫球蛋白结合蛋白及其制备方法和应用
CN112461943A (zh) * 2020-10-12 2021-03-09 河南省奶牛生产性能测定有限公司 一种牛乳中免疫球蛋白igG高效液相色谱检测方法
WO2022081779A1 (en) 2020-10-13 2022-04-21 Avitide LLC Affinity ligand libraries of three-helix bundle proteins and uses thereof
GB202018588D0 (en) 2020-11-26 2021-01-13 Cytiva Bioprocess R & D Ab Separation matrix
WO2022136440A1 (en) 2020-12-21 2022-06-30 Syngenta Crop Protection Ag Pesticidal hexatoxin polypeptides and methods of use thereof
JP2024508587A (ja) 2021-02-19 2024-02-28 アヴィタイド エルエルシー Ａａｖ２親和剤
KR20230174238A (ko) 2021-04-21 2023-12-27 니혼 메디피직스 가부시키가이샤 방사성 항종양제
CA3217638A1 (en) 2021-04-21 2022-10-27 Nihon Medi-Physics Co., Ltd. Humanised antibodies labelled with radionuclides that emit .beta.-rays
GB2609185A (en) 2021-05-24 2023-02-01 Astrea Uk Services Ltd Scaffold for isolation of a biomolecule
GB202109246D0 (en) 2021-06-28 2021-08-11 Cytiva Bioprocess R & D Ab A method of separating bispecific antibodies
GB202113626D0 (en) 2021-09-24 2021-11-10 Cytiva Bioprocess R & D Ab FC binding polypeptides
CN114315996B (zh) * 2021-12-31 2023-01-17 博格隆(浙江)生物技术有限公司 一种重组ProteinA蛋白及亲和层析介质的制备方法
CN114409748A (zh) * 2022-01-28 2022-04-29 博格隆(浙江)生物技术有限公司 蛋白a的b结构域和z结构域突变体及其应用
GB202203478D0 (en) 2022-03-14 2022-04-27 Cytiva Bioprocess R & D Ab Vh3 binding polypeptides
CN114605508B (zh) * 2022-05-11 2022-07-29 北京达成生物科技有限公司 能够结合于抗体分子Fc区域的抗体结合蛋白及其应用
CN117700501A (zh) * 2022-09-13 2024-03-15 普米斯生物技术(珠海)有限公司 免疫球蛋白结合蛋白及其应用
CN117024529B (zh) * 2023-07-17 2024-01-26 北京达成生物科技有限公司 抗体结合蛋白及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8505922D0 (sv) 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
WO1993002107A1 (en) 1991-07-25 1993-02-04 Oriental Yeast Co., Ltd. Immunoglobulin-combining artificial protein
SE9400088D0 (sv) * 1994-01-14 1994-01-14 Kabi Pharmacia Ab Bacterial receptor structures
US5834597A (en) * 1996-05-20 1998-11-10 Protein Design Labs, Inc. Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
GB9823071D0 (en) 1998-10-21 1998-12-16 Affibody Technology Ab A method
US7709209B2 (en) * 2002-03-25 2010-05-04 Ge Healthcare Bio-Sciences Ab Protein ligands
SE0200943D0 (sv) * 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
JP4871126B2 (ja) * 2003-07-04 2012-02-08 アフィボディ・アーベー Ｈｅｒ２に対する結合親和性を有するポリペプチド
US8728828B2 (en) * 2004-12-22 2014-05-20 Ge Healthcare Bio-Sciences Ab Purification of immunoglobulins
ATE490268T1 (de) * 2005-03-01 2010-12-15 Affibody Ab Tnf-alhpa-bindendes polypeptid, anwendungen davon und verfahren, bei denen dieses verwendet wird
CN102272145B (zh) * 2009-01-12 2014-07-30 通用电气健康护理生物科学股份公司 亲和色谱基质
US9051375B2 (en) * 2010-12-21 2015-06-09 The University Of Western Ontario Alkali-resistant variants of protein A and their use in affinity chromatography
US9896486B2 (en) * 2013-07-10 2018-02-20 Ge Healthcare Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US11566082B2 (en) * 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US10654887B2 (en) * 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
US10730908B2 (en) * 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US10703774B2 (en) * 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method

Also Published As

Publication number Publication date
US7834158B2 (en) 2010-11-16
DE60327606D1 (de) 2009-06-25
EP1485407A1 (en) 2004-12-15
KR101067181B1 (ko) 2011-09-22
CN1642976A (zh) 2005-07-20
EP3249047B1 (en) 2020-02-19
US9534023B2 (en) 2017-01-03
KR20120125674A (ko) 2012-11-16
US20210162319A1 (en) 2021-06-03
US20110112276A1 (en) 2011-05-12
US8198404B2 (en) 2012-06-12
JP2005538693A (ja) 2005-12-22
US20120238724A1 (en) 2012-09-20
EP1972689A3 (en) 2008-11-19
US20100022760A1 (en) 2010-01-28
AU2003217119A1 (en) 2003-10-08
ES2325362T3 (es) 2009-09-02
CA2479896C (en) 2015-11-17
ES2325362T5 (es) 2013-02-20
ES2634145T3 (es) 2017-09-26
US20060194950A1 (en) 2006-08-31
CN102516371A (zh) 2012-06-27
KR101307651B1 (ko) 2013-09-12
US9156892B2 (en) 2015-10-13
KR20110004456A (ko) 2011-01-13
CN102516372A (zh) 2012-06-27
EP1485407B2 (en) 2012-09-26
EP1972689B1 (en) 2017-06-07
KR101307714B1 (ko) 2013-09-11
CN102558317A (zh) 2012-07-11
ES2783876T3 (es) 2020-09-18
EP3249047A3 (en) 2018-02-28
DK3249047T3 (en) 2020-03-30
JP4391830B2 (ja) 2009-12-24
CN102558318A (zh) 2012-07-11
KR20040099368A (ko) 2004-11-26
US8354510B2 (en) 2013-01-15
CN102532284A (zh) 2012-07-04
KR20120126129A (ko) 2012-11-20
WO2003080655A1 (en) 2003-10-02
EP1972689A2 (en) 2008-09-24
AU2003217119B2 (en) 2010-02-18
ATE431360T1 (de) 2009-05-15
KR101307700B1 (ko) 2013-09-11
US10918971B2 (en) 2021-02-16
US9296791B2 (en) 2016-03-29
US20050143566A1 (en) 2005-06-30
DK1972689T3 (da) 2017-08-14
US20160152668A1 (en) 2016-06-02
EP1485407B1 (en) 2009-05-13
US20130184438A1 (en) 2013-07-18
CN102532284B (zh) 2014-04-16
CA2479896A1 (en) 2003-10-02
US20170080358A1 (en) 2017-03-23
EP3249047A2 (en) 2017-11-29
CN1642976B (zh) 2012-02-22

Similar Documents

Publication Publication Date Title
SE0200943D0 (sv) Mutant protein
WO2004035752A3 (en) ALTERATION OF FcRn BINDING AFFINITIES OR SERUM HALF-LIVES OF ANTIBODIES BY MUTAGENESIS
BRPI0409269A (pt) anticorpo modificado da classe igg e método de produção do mesmo
WO2008048545A3 (en) Molecules with reduced half-lives, compositions and uses thereof
EP2157099B1 (en) Novel immunoglobulin-binding proteins with improved specificity
PL1601770T3 (pl) Antygeny Streptococcus pyogenes
AU2002367839A8 (en) Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
WO2005037867B1 (en) ALTERATION OF Fc-FUSION PROTEIN SERUM HALF-LIVES BY MUTAGENESIS OF POSITIONS 250, 314 AND/OR 428 OF THE HEAVY CHAIN CONSTANT REGION OF IG
WO2004074310A8 (en) Mycobacterial diagnostics
NO20025656D0 (no) Opplöselige CTLA4 mutantmolekyler og anvendelser derav
JP2008506960A5 (da)
McCue et al. Validation of the manufacturing process used to produce long‐acting recombinant factor IX Fc fusion protein
PT1944371E (pt) Antigénios e composições da neisseria meningitidis
WO2004081186A3 (en) Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof
RU2010125489A (ru) Способ характеризации рекомбинантного поликлонального белка
JPWO2006001300A1 (ja) 高耐久性液体クロマトグラフィー用充填剤
Krepper et al. Temperature dependence of antibody adsorption in protein A affinity chromatography
Yoshida et al. Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.
EP1960427A4 (en) MULTIMED FC RECEPTOR POLYPEPTIDES
ATE480573T1 (de) Pfropfcopolymere, deren herstellung und verwendung bei der kapillarelektrophorese
WO2006073971A3 (en) Binding protein with a scaffold for varying specificity
WO2004106367A3 (en) Enterococcus antigens
WO2002062988A3 (en) Recombination method
WO2002095067A3 (en) INTERFERON α-14 POLYMORPHISM
ATE350387T1 (de) Verfahren zur reinigung von molekülen unter verwendung von unverzweigten alkyldiolen mit einständigen hydroxylgruppen